Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.

Yu XW, Wu TY, Yi X, Ren WP, Zhou ZB, Sun YQ, Zhang CQ.

Tumour Biol. 2014 Jan;35(1):155-60. doi: 10.1007/s13277-013-1019-1. Epub 2013 Aug 2.

PMID:
23907576
2.

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.

Peng L, Zhan P, Zhou Y, Fang W, Zhao P, Zheng Y, Xu N.

Mol Biol Rep. 2012 Oct;39(10):9473-84. doi: 10.1007/s11033-012-1812-8. Epub 2012 Jun 23.

PMID:
22729879
3.

The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review.

Qu JT, Wang M, He HL, Tang Y, Ye XJ.

J Cancer Res Clin Oncol. 2012 May;138(5):819-25. doi: 10.1007/s00432-012-1149-7. Epub 2012 Jan 25. Review.

PMID:
22274866
4.

Prognostic value of vascular endothelial growth factor A expression in gastric cancer: a meta-analysis.

Ji YN, Wang Q, Li Y, Wang Z.

Tumour Biol. 2014 Mar;35(3):2787-93.

PMID:
24234334
5.

Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysis.

Zhan P, Qian Q, Yu LK.

Hepatobiliary Surg Nutr. 2013 Jun;2(3):148-55. doi: 10.3978/j.issn.2304-3881.2013.06.06.

6.

VEGF-C expression is associated with the poor survival in gastric cancer tissue.

Cao W, Fan R, Yang W, Wu Y.

Tumour Biol. 2014 Apr;35(4):3377-83. doi: 10.1007/s13277-013-1445-0. Epub 2013 Dec 5.

PMID:
24307624
7.

VEGF is associated with the poor survival of patients with prostate cancer: a meta-analysis.

Zhan P, Ji YN, Yu LK.

Transl Androl Urol. 2013 Jun;2(2):99-105. doi: 10.3978/j.issn.2223-4683.2013.06.03.

8.
9.

Prognostic significance of VEGF immunohistochemical expression in oral cancer: a meta-analysis of the literature.

Zhao SF, Yang XD, Lu MX, Sun GW, Wang YX, Zhang YK, Pu YM, Tang EY.

Tumour Biol. 2013 Oct;34(5):3165-71. doi: 10.1007/s13277-013-0886-9. Epub 2013 Jun 5.

PMID:
23737289
10.

Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.

Zhuang Y, Wei M.

Tumour Biol. 2014 Mar;35(3):1745-9. doi: 10.1007/s13277-014-1692-8. Epub 2014 Feb 11.

PMID:
24515658
11.

Comment on Xu XW et al.: Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.

He S, Xiao Z, Chen L, Xiong S.

Tumour Biol. 2014 Jul;35(7):6193-4. doi: 10.1007/s13277-014-2024-8. Epub 2014 May 23. No abstract available.

PMID:
24852425
12.

Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis.

Zhan P, Qian Q, Yu LK.

Hepatobiliary Surg Nutr. 2013 Aug;2(4):209-15. doi: 10.3978/j.issn.2304-3881.2013.06.07.

13.

Matrix metalloproteinase 9 expression and survival of patients with osteosarcoma: a meta-analysis.

Liu Y, Wang Y, Teng Z, Chen J, Li Y, Chen Z, Li Z, Zhang Z.

Eur J Cancer Care (Engl). 2017 Jan;26(1). doi: 10.1111/ecc.12364. Epub 2015 Aug 4. Review.

PMID:
26239566
14.

Prognostic significance of COX-2 immunohistochemical expression in colorectal cancer: a meta-analysis of the literature.

Peng L, Zhou Y, Wang Y, Mou H, Zhao Q.

PLoS One. 2013;8(3):e58891. doi: 10.1371/journal.pone.0058891. Epub 2013 Mar 20.

15.

Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.

Wen X, Liu H, Yu K, Liu Y.

Tumour Biol. 2014 Jan;35(1):845-8. doi: 10.1007/s13277-013-1116-1. Epub 2013 Sep 15.

PMID:
24037915
16.

A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.

Chen D, Zhang YJ, Zhu KW, Wang WC.

Tumour Biol. 2013 Jun;34(3):1895-9. doi: 10.1007/s13277-013-0733-z. Epub 2013 Apr 16. Review.

PMID:
23589053
17.

Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis.

Zhan P, Wang J, Lv XJ, Wang Q, Qiu LX, Lin XQ, Yu LK, Song Y.

J Thorac Oncol. 2009 Sep;4(9):1094-103. doi: 10.1097/JTO.0b013e3181a97e31. Review.

18.

The associations of vascular endothelial growth factor gene polymorphisms with susceptibility to osteosarcoma: evidence from a meta-analysis.

Zhao J, Chen ZQ, Li GW, Yang M, Shao J, Li M.

Eur J Cancer Care (Engl). 2017 Sep;26(5). doi: 10.1111/ecc.12513. Epub 2016 May 3.

PMID:
27144378
19.

Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma.

Han G, Wang Y, Bi W, Jia J, Wang W, Xu M.

Clin Exp Med. 2016 Nov;16(4):577-584. Epub 2015 Aug 29.

PMID:
26319790
20.

Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis.

Guo S, Bai R, Zhao W, Wang Y, Zhao Z, Feng W.

Tumour Biol. 2014 Jan;35(1):469-73.

PMID:
23959472

Supplemental Content

Support Center